DXCM vs EW
Dexcom vs Edwards Lifesciences — AI-powered side-by-side comparison
| Metric | DXCM | EW |
|---|---|---|
| AI Score | 72 | 73 |
| Price | $74.97 | $92.17 |
| P/E Ratio | 29.30× | 48.46× |
| ROE | 33.8% | 10.6% |
| Revenue Growth YoY | 16.1% | 13.8% |
| Gross Margin | 63.4% | 77.9% |
| Debt / Equity | 0.47× | 0.06× |
| Dividend Yield | — | — |
| RSI (14) | 66.1 | 54.5 |
| Beta | 1.4277 | 0.8325 |
| Expected Upside | +1.3% | +2.9% |
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
DXCM Full Analysis
EW Full Analysis